1-20 of 60
Keith Wheatley
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial

Clinical Trials & Observations
Sridhar Chaganti, Shanna Maycock, Graham McIlroy, Aimee Jackson, Rebecca Bishop, Sarah Johnson, Edward Kanfer, Shireen Kassam, Kate Cwynarski, David Wrench, Arvind Arumainathan, Christopher P. Fox, Rod Johnson, Pam McKay, Shankara Paneesha, Clare Rowntree, Constantine Balotis, Graham P. Collins, Andrew Davies, Josh Wright, Sarah Burns, Arian Laurence, Keith Wheatley, Tobias Menne
Journal: Blood
Blood (2024) 144 (4): 392–401.
https://doi.org/10.1182/blood.2024023847
Published: 2024
Includes: Supplemental data
Journal Articles

Risk-Stratified Sequential Treatment with Ibrutinib and Rituximab (IR) and IR-CHOP for De-Novo Post-Transplant Lymphoproliferative Disorder: Results of the Tidal Trial

Sridhar Chaganti, Shanna Maycock, Graham McIlroy, Waleed A Iqbal, John Mason, Edward Kanfer, Shireen Kassam, Kate Cwynarski, David Wrench, Arvind K. Arumainathan, Christopher P Fox, Rod Johnson, Pam McKay, Shankara Paneesha, Clare J Rowntree, Constantine-George Balotis, Graham P. Collins, Andrew Davies, Josh Wright, Keith Wheatley, Tobias F Menne
Journal: Blood
Blood (2021) 138 (Supplement 1): 2492.
https://doi.org/10.1182/blood-2021-146494
Published: 2021
Journal Articles

The Sequential Flamsa-Bu Conditioning Regimen Does Not Improve Outcome in Patients Allografted for High Risk Acute Myeloid and Myelodysplasia Irrespective of Pre-Transplant MRD Status: Results of the UK NCRI Figaro Trial

Charles Craddock, FRCP, FRCPath, Aimee E Jackson, MSc, Ram K Malladi, FRCPath, Maria H Gilleece, MD FRCPath, MB, BSc, FRCP, Andy Peniket, MD, Rahuman Salim, MRCP, FRCPath, Eleni Tholouli, MD PhD, Victoria Potter, MD PhD, Charles R Crawley, Rachel Elizabeth Protheroe, FRCPath,PhDMBBS,FRCP, Anne Parker, MD FRCP, BSc, FRCPath, Keith Wilson, FRCPath, MRCP, MBBS, Jiri Pavlu, MDMRCP,FRCPath, Sandeep Nagra, MBChB, Shamyla Siddique, BSc.(Hons.), MPhil, Andrea Hodgkinson, BSc(Hons),PhD, John Mason, Keith Wheatley, DPhil, Nigel H. Russell, MD, Sylvie D. Freeman, MBChB, DPhil
Journal: Blood
Blood (2019) 134 (Supplement_1): 2031.
https://doi.org/10.1182/blood-2019-125646
Published: 2019
Journal Articles

Molecular MRD Monitoring Is Feasible in the Majority of Children with AML and Is Highly Predictive of Outcome: Results from the International MyeChild01 Study

Jelena Jovanovic, PhD, Nicola Potter, PhD, Anju Kanda, MSc, Claire Schwab, PhD, Aimee E Jackson, MSc, Richard Dillon, MA, PhD MRCP, FRCPath, Anna Lawson, BSc, Manohursingh Runglall, MSc, Paresh Vyas, MD PhD, Paul Virgo, Geoff Shenton, Nicholas Heaney, Beki James, MD, Katharine Patrick, MD, Persis J Amrolia, FRCP, FRCPath, PhD, Jean-Hugues Dalle, MD PhD, Gerard Michel, MD, Andrew S. Moore, MBBS,FRACP,PhD, Hélène Lapillonne, MD PhD, Claude Preudhomme, PharmD, PhD, Guy Leverger, MD, Owen P Smith, MD, Andre Baruchel, MD, Yves Bertrand, MD, Arnaud Petit, MD PhD, Keith Wheatley, DPhil, Pamela R. Kearns, PhDFRCPC, Christine J. Harrison, PhD FRCPath, Brenda Gibson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1393.
https://doi.org/10.1182/blood-2019-125257
Published: 2019
Journal Articles

Intensified Dosing of Gemtuzumab Ozogamicin Can be Safely Combined with Induction Chemotherapy in Children with Acute Myeloid Leukaemia (AML) and High Risk Myelodysplasia (MDS)

Brenda Gibson, MD PhD, Aimee E Houlton, BSc, MSc, Andre Baruchel, MD, Guy Leverger, MD PhD, Owen P Smith, MD, Anna Lawson, BSc, Keith Wheatley, DPhil, Pamela R. Kearns, PhD FRCPC
Journal: Blood
Blood (2018) 132 (Supplement 1): 2681.
https://doi.org/10.1182/blood-2018-99-115899
Published: 2018
Journal Articles

Hydroxycarbamide Plus Aspirin Vs Aspirin Alone in Intermediate Risk Essential Thrombocythemia: Results of the PT-1 International, Prospective, Randomized Clinical Trial

Anna L. Godfrey, BMBCh, PhD MRCP, FRCPath, Peter J Campbell, MD PhD, Cathy MacLean, BSc, MSc, MBA, Georgina Buck, BSc, MSc, Clare L. East, BSc, Julia Cook, BSc, Julie Temple, BSc, Bridget S. Wilkins, MD FRCPath, Keith Wheatley, DPhil, Jyoti Nangalia, MBBChir, MA, MRCP, FRCPath, PhD, Jacob Grinfeld, MBChB, BSc, MRCP, FRCPath, Mary Frances Frances McMullin, MB,Bch BAO, MD FRCPath, Cecily Forsyth, MB BS, Jean-Jacques Kiladjian, MD PhD, Anthony R. Green, FRCP, FRCPath, FMed Sci, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath
Journal: Blood
Blood (2017) 130 (Supplement 1): 319.
https://doi.org/10.1182/blood.V130.Suppl_1.319.319
Published: 2017
Journal Articles

Results of Inter-B-NHL Ritux 2010 - Phase II Study of DA-EPOCH-R for Children and Adolescents with Primary Mediastinal Large B-Cell Lymphoma (PMLBL) on Behalf of European Intergroup for Childhood Non Hodgkin's Lymphoma (EICNHL) and Children's Oncology Group (COG)

G A Amos Burke, Thomas G. Gross, MD PhD, Marta Pillon, Veronique Minard-colin, Raphael F Delgado, József Zsíros, Anne Uyttebroeck, Jean Michon, Catherine M. Bollard, MD FRACP, FRCPA, Monika Csoka, Donald A Barkauskas, Keith Wheatley, DPhil, Anne Aupérin, Catherine Patte
Journal: Blood
Blood (2017) 130 (Supplement 1): 4124.
https://doi.org/10.1182/blood.V130.Suppl_1.4124.4124
Published: 2017
Journal Articles

Vorinostat Does Not Improve Outcome in Patients with Acute Myeloid Leukemia and High Risk Myelodysplasia Treated with Azacitidine: Results of the UK Trials Acceleration Programme Ravva Trial

Charles Craddock, MD PhD, Aimee E Houlton, BSc, MSc, Paul Ferguson, MBChB MRCP PhD, Manoj Raghavan, Sonia Fox, Louise Dudley, BSc, MRes, Lynn Swun Quek, FRCPath, DPhil, MBBS, Jamie D. Cavenagh, Michael Dennis, FRCPath, Mary Frances McMullin, MD, Srinivas P Pillai, Richard Kelly, BSc, MD, Shamyla Siddique, Keith Wheatley, DPhil, Paresh Vyas, BM, DPhil, FRCP, FRCPath
Journal: Blood
Blood (2016) 128 (22): 1065.
https://doi.org/10.1182/blood.V128.22.1065.1065
Published: 2016
Journal Articles

Clofarabine doubles the response rate in older patients with acute myeloid leukemia but does not improve survival

Clinical Trials & Observations
Alan K. Burnett, Nigel H. Russell, Ann E. Hunter, Donald Milligan, Steven Knapper, Keith Wheatley, John Yin, Mary F. McMullin, Sahra Ali, David Bowen, Robert K. Hills
Journal: Blood
Blood (2013) 122 (8): 1384–1394.
https://doi.org/10.1182/blood-2013-04-496596
Published: 2013
Journal Articles

Maintenance Therapies for Multiple Myeloma (MM): A Direct Meta-Analysis

Helen Mahony, MPH, Ambuj Kumar, MD, MPH, Rahul Mhaskar, MPH, PhD, Branko Miladinovic, PhD, Keith Wheatley, Benjamin Djulbegovic, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4271.
https://doi.org/10.1182/blood.V120.21.4271.4271
Published: 2012
Journal Articles

Trial Sequential Analysis in Meta-Analyses of Maintenance Therapies for Multiple Myeloma.

Branko Miladinovic, PhD, Ambuj Kumar, MD, MPH, Rahul Mhaskar, MPH, PhD, Helen Mahoney, MPH, Keith Wheatley, Benjamin Djulbegovic, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2975.
https://doi.org/10.1182/blood.V120.21.2975.2975
Published: 2012
Journal Articles

Maintenance Therapies for Multiple Myeloma (MM): A Network Meta-Analysis

Helen Mahony, MPH, Ambuj Kumar, MD, MPH, Rahul Mhaskar, MPH, PhD, Branko Miladinovic, PhD, Keith Wheatley, Benjamin Djulbegovic, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 236.
https://doi.org/10.1182/blood.V120.21.236.236
Published: 2012
Journal Articles

Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial

Clinical Trials & Observations
John A. Liu Yin, Michelle A. O'Brien, Robert K. Hills, Sarah B. Daly, Keith Wheatley, Alan K. Burnett
Journal: Blood
Blood (2012) 120 (14): 2826–2835.
https://doi.org/10.1182/blood-2012-06-435669
Published: 2012
Includes: Supplemental data
Journal Articles

Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort

Brief Report
Peter J. Campbell, Cathy MacLean, Philip A. Beer, Georgina Buck, Keith Wheatley, Jean-Jacques Kiladjian, Cecily Forsyth, Claire N. Harrison, Anthony R. Green
Journal: Blood
Blood (2012) 120 (7): 1409–1411.
https://doi.org/10.1182/blood-2012-04-424911
Published: 2012
Journal Articles

The Addition of Gemtuzumab Ozogamicin to Intensive Chemotherapy in Older Patients with AML Produces a Significant Improvement in Overall Survival: Results of the UK NCRI AML16 Randomized Trial

Alan K Burnett, MD, Robert K Hills, MA, MSc, DPhil, Ann E. Hunter, MBBS, FRCP, FRCPath, Donald Milligan, MD, MBChB, William J. Kell, MD, MB, Keith Wheatley, John L Yin, MD, Sahra Ali, FRCPath, FRCP, BM, MRCP, MRCPath, Lars Kjeldsen, MD, PhD, David Bowen, Nigel H. Russell, MD
Journal: Blood
Blood (2011) 118 (21): 582.
https://doi.org/10.1182/blood.V118.21.582.582
Published: 2011
Journal Articles

The Addition of Gemtuzumab Ozogamicin to Low Dose Ara-C Improves Remission Rates but Not Survival: Results of the UK LRF AML14 and NCRI AML16 “Pick a Winner” Comparison

Alan Burnett, Robert Hills, MA, MSc, DPhil, Ann Elizabeth Hunter, MBBS, FRCP, FRCPath, Donald Milligan, MD, FRCP, FRCPath, William J. Kell, MD, MB, Keith Wheatley, John Yin, MD, Mary Frances McMullin, MD, Helen Dignum, David Bowen, Nigel H. Russell, MD
Journal: Blood
Blood (2010) 116 (21): 18.
https://doi.org/10.1182/blood.V116.21.18.18
Published: 2010
Journal Articles

Comparative Effectiveness of Bisphoshonates In Multiple Myeloma

Rahul Mhaskar, MD, MPH, Jasmina Redzepovic, Keith Wheatley, Otavio Clark, Axel Glasmacher, MD, Branko Miladinovic, PhD, Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3028.
https://doi.org/10.1182/blood.V116.21.3028.3028
Published: 2010
Journal Articles

Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

Clinical Trials & Observations
David Grimwade, Robert K. Hills, Anthony V. Moorman, Helen Walker, Stephen Chatters, Anthony H. Goldstone, Keith Wheatley, Christine J. Harrison, Alan K. Burnett, on behalf of the National Cancer Research Institute Adult Leukaemia Working Group
Journal: Blood
Blood (2010) 116 (3): 354–365.
https://doi.org/10.1182/blood-2009-11-254441
Published: 2010
Includes: Supplemental data
Journal Articles

The impact on outcome of the addition of all- trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1 , FLT3 , and CEBPA

Clinical Trials & Observations
Alan K. Burnett, Robert K. Hills, Claire Green, Sarah Jenkinson, Kenneth Koo, Yashma Patel, Carol Guy, Amanda Gilkes, Donald W. Milligan, Anthony H. Goldstone, Archibald G. Prentice, Keith Wheatley, David C. Linch, Rosemary E. Gale
Journal: Blood
Blood (2010) 115 (5): 948–956.
https://doi.org/10.1182/blood-2009-08-236588
Published: 2010
Includes: Supplemental data
Journal Articles

Bisphosphonates in Multiple Myeloma. A Systematic Review and Meta Analysis.

Rahul Suresh Mhaskar, MPH, Jasmina Redzepovic, PhD, Keith Wheatley, DPhil, Otavio Clark, MD, PhD, Axel Glasmacher, MD, Ambuj Kumar, MD, MPH, Benjamin Djulbegovic, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3858.
https://doi.org/10.1182/blood.V114.22.3858.3858
Published: 2009